Literature DB >> 26941991

Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes.

Harveshp Mogal1, Konstantinos Chouliaras1, Edward A Levine1, Perry Shen1, Konstantinos I Votanopoulos1.   

Abstract

Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an established treatment option in selected patients with peritoneal dissemination from a variety of epithelial primaries. Even though a small proportion will be alive and potentially cured at 10 years, the majority will eventually develop recurrent disease. Repeat CRS/HIPEC is a valid consideration in a selected subpopulation of patients with isolated peritoneal recurrence. This review summarizes the data on patient selection, feasibility, limitations and outcomes of repeat CRS/HIPEC.

Entities:  

Keywords:  Repeat cytoreduction; hyperthermic intraperitoneal chemotherapy (HIPEC)

Year:  2016        PMID： 26941991      PMCID： PMC4754305          DOI： 10.3978/j.issn.2078-6891.2015.131

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  94 in total

Review 1.  Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.

Authors:  Terence C Chua; Greg Robertson; Winston Liauw; Rhonda Farrell; Tristan D Yan; David L Morris
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-23       Impact factor: 4.553

2.  External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer.

Authors:  Rafli van de Laar; Leon F A G Massuger; Toon Van Gorp; Joanna IntHout; Petra L M Zusterzeel; Roy F P M Kruitwagen
Journal:  Gynecol Oncol       Date:  2015-02-10       Impact factor: 5.482

3.  Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Hidde J Braam; Thijs R van Oudheusden; Ignace H J T de Hingh; Simon W Nienhuijs; Djamila Boerma; Marinus J Wiezer; Bert van Ramshorst
Journal:  J Surg Oncol       Date:  2014-03-12       Impact factor: 3.454

Review 4.  Epidemiology of peritoneal mesothelioma: a review.

Authors:  P Boffetta
Journal:  Ann Oncol       Date:  2006-10-09       Impact factor: 32.976

5.  Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.

Authors:  Vic J Verwaal; Henk Boot; Berthe M P Aleman; Harm van Tinteren; Frans A N Zoetmulder
Journal:  Ann Surg Oncol       Date:  2004-03-15       Impact factor: 5.344

6.  Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Authors:  Andrew L Feldman; Steven K Libutti; James F Pingpank; David L Bartlett; Tatiana H Beresnev; Sharon M Mavroukakis; Seth M Steinberg; David J Liewehr; David E Kleiner; H Richard Alexander
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

7.  Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.

Authors:  Edward A Levine; John H Stewart; Perry Shen; Gregory B Russell; Brian L Loggie; Konstantinos I Votanopoulos
Journal:  J Am Coll Surg       Date:  2013-12-21       Impact factor: 6.113

8.  Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer.

Authors:  Harriet O Smith; James Moon; Sharon P Wilczynski; Amy D Tiersten; Edward V Hannigan; William R Robinson; Saul E Rivkin; Garnet L Anderson; P Y Liu; Maurie Markman
Journal:  Gynecol Oncol       Date:  2009-05-23       Impact factor: 5.482

9.  Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Authors:  Lana Bijelic; Tristan D Yan; Paul H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2007-05-15       Impact factor: 5.344

10.  Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study.

Authors:  Rafli van de Laar; Petra L M Zusterzeel; Toon Van Gorp; Marrije R Buist; Willemien J van Driel; Katja N Gaarenstroom; Henriette J G Arts; Johannes C M van Huisseling; Ralph H M Hermans; Johanna M A Pijnenborg; Eltjo M J Schutter; Harold M P Pelikan; Jos H A Vollebergh; Mirjam J A Engelen; Joanna Inthout; Roy F P M Kruitwagen; Leon F A G Massuger
Journal:  BMC Cancer       Date:  2014-01-14       Impact factor: 4.430
View more
  10 in total

1.  Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin.

Authors:  Toshiyuki Kitai; Kenya Yamanaka
Journal:  Int J Clin Oncol       Date:  2017-11-27       Impact factor: 3.402

2.  Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.

Authors:  Benjamin D Powers; Seth Felder; Jula Veerapong; Joel M Baumgartner; Callisia Clarke; Harveshp Mogal; Charles A Staley; Shishir K Maithel; Sameer Patel; Vikrom Dhar; Laura Lambert; Ryan J Hendrix; Daniel E Abbott; Courtney Pokrzywa; Mustafa Raoof; Byrne Lee; Fabian M Johnston; Jonathan Greer; Jordan M Cloyd; Charles Kimbrough; Travis Grotz; Jennifer Leiting; Keith Fournier; Andrew J Lee; Iman Imanirad; Sophie Dessureault; Sean P Dineen
Journal:  Ann Surg Oncol       Date:  2020-04-21       Impact factor: 5.344

3.  Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.

Authors:  Haroon A Choudry; Filip Bednar; Yongli Shuai; Heather L Jones; Reetesh K Pai; James F Pingpank; Steven S Ahrendt; Matthew P Holtzman; Herbert J Zeh; David L Bartlett
Journal:  Ann Surg Oncol       Date:  2019-03-01       Impact factor: 5.344

4.  Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Christopher W Mangieri; Cristian D Valenzuela; Richard A Erali; Konstantinos I Votanopoulos; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2021-08-28       Impact factor: 5.344

5.  Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?

Authors:  Christopher W Mangieri; Cristian D Valenzuela; Ian B Solsky; Richard A Erali; Konstantinos I Votanopoulos; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2022-08-15       Impact factor: 4.339

6.  Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS.

Authors:  Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2022-02-18       Impact factor: 4.339

7.  Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.

Authors:  Frédéric Dumont; Hélène Senellart; Francois Pein; Loic Campion; Olivier Glehen; Diane Goere; Marc Pocard; Emilie Thibaudeau
Journal:  Pleura Peritoneum       Date:  2018-09-15

8.  Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei.

Authors:  Anthony R Lam; Khalil Bazzi; Sarah J Valle; David L Morris
Journal:  Case Rep Oncol       Date:  2021-03-31

9.  A Versatile Theranostic Platform for Colorectal Cancer Peritoneal Metastases: Real-Time Tumor-Tracking and Photothermal-Enhanced Chemotherapy.

Authors:  Tao Sun; Guangping Zhang; Tingting Ning; Qinjun Chen; Yongchao Chu; Yifan Luo; Haoyu You; Boyu Su; Chao Li; Qin Guo; Chen Jiang
Journal:  Adv Sci (Weinh)       Date:  2021-08-16       Impact factor: 16.806

10.  A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei.

Authors:  Kenya Yamanaka; Norishige Iizuka; Toshiyuki Kitai
Journal:  Surg Case Rep       Date:  2021-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.